This Beatbot robotic pool cleaner gets all the leaves — 47% off for Prime Day
Why you should buy the Beatbot iSkim Ultra robotic pool cleaner
The Beatbot iSkim Ultra is a smart robotic pool cleaner with a seven-motor system that promises fantastic cleaning efficiency, AI algorithms for obstacle avoidance, and dual-side and front roller brushes for extended coverage in capturing debris. The device is also equipped with 20 sensors for advanced scanning and path planning, allowing it to make sure that every part of your swimming pool's surface — including corners and edges — will be cleaned.
The 24W solar panel of the Beatbot iSkim Ultra robotic pool cleaner keeps it running throughout the day, and its 10,000 mAh battery takes over when the sun is gone. You can also use the device with Beatbot's ClearWater Clarification system, which uses an eco-friendly and natural clarifier to remove oil, dirt, and metal residue in your pool to avoid discoloration and scum buildup. The Beatbot iSkim Ultra works with the Beatbot app, through which you can activate water clarification, schedule cleaning sessions, and monitor the robotic pool cleaner's status, among many other functions.
The Beatbot iSkim Ultra will help make pool maintenance much easier, and it's a very tempting purchase right now at 47% off for Prime Day. It's down to just $799 from $1,499 for a huge $700 discount, but you're going to have to hurry as the stocks that are up for sale during the shopping event may not last much longer. Add the Beatbot iSkim Ultra robotic pool cleaner to your cart and finish the checkout process as soon as you can if you want to take advantage of this opportunity to get it at almost half its original price.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a few seconds ago
- Yahoo
Trump weighing lawsuit against Fed's Powell over renovations, White House says
WASHINGTON (Reuters) -U.S. President Donald Trump is considering a lawsuit against Federal Reserve Chair Jerome Powell related to his management of renovations at the Fed's Washington headquarters, White House spokeswoman Karoline Leavitt said on Tuesday. The potential move, suggested earlier in a presidential social media post, escalates Trump's continuing pressure on the central bank leader to cut interest rates. A Fed spokesperson did not have a comment. White House officials have said they are investigating renovations of two historic buildings by the Fed, suggesting poor oversight and potential fraud have driven up the cost unnecessarily and that the project is inappropriately ostentatious to boot. Trump visited the site a couple of weeks ago and repeated those accusations, even as he met with Powell and made his case in person for cutting interest rates. Fed documents show the cost, originally estimated at $1.9 billion, is now budgeted at $2.4 billion, and the central bank says the extra expenses are mostly due to higher labor and materials costs as well as unexpected challenges, including asbestos abatement. A Supreme Court opinion issued this summer in an unrelated case about employees of other independent government agencies backs the idea that the Fed is unique and that the law does not allow the president to remove a Fed chair because of differences over the direction of monetary policy. (Reporting By Steve Holland and Jarrett Renshaw; Editing by Mark Porter and Rod Nickel)
Yahoo
a few seconds ago
- Yahoo
Cardinal Health (CAH) Reports US$1,561 Million Net Income With Strong Earnings Per Share Growth
Cardinal Health recently reported strong financial performance, showing significant growth in net income and earnings per share for the year ended June 30, 2025, despite a slight dip in sales. This operational efficiency, coupled with strategic product-related announcements such as the launch of a new monitoring system and a significant distribution agreement, may have provided positive sentiment that contributed to a 6% price increase over the last quarter. The share price movement aligned with broader market trends, as major indices such as the S&P 500 and Nasdaq Composite reached record highs amid anticipated Federal Reserve interest rate reductions. You should learn about the 1 weakness we've spotted with Cardinal Health. AI is about to change healthcare. These 25 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early. The recent financial achievements and strategic initiatives at Cardinal Health could reinforce the company's broader growth strategy. The introduction of new products and significant distribution agreements are expected to bolster revenue and earnings, reflecting the company's focus on operational efficiency and expanding high-margin businesses. These developments are crucial as analysts foresee revenue growing to US$283.3 billion and earnings reaching US$2.1 billion by 2028. Such growth aligns with the broader industry trends and demonstrates the company's ability to adapt to changing market conditions. Over a five-year period, Cardinal Health has provided a total shareholder return of 242.03%. This long-term performance offers a formidable contrast to recent short-term movements, reflected in the 6% increase over the last quarter. In the past year, CAH outperformed the US Healthcare industry, which saw a significant decline of 33%, further establishing its resilience. Similarly, compared to the US Market's return of 20.2%, CAH has managed to stay ahead, reflecting its robust positioning in the market. Despite a current share price of US$157.66, the consensus analyst price target stands at US$179.93, indicating a potential upward move. The valuation reflects expectations that CAH will maintain its growth trajectory, with a forecasted increase in profit margins and reduced share count enhancing earnings per share. However, the company's price-to-earnings ratio remains above the industry average, which some might view as a premium. Importantly, analysts express some disagreement regarding future outcomes, highlighting the need for investors to carefully consider potential risks alongside growth opportunities. Gain insights into Cardinal Health's future direction by reviewing our growth report. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include CAH. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
a few seconds ago
- Yahoo
InventHelp Inventor Develops Robot with Humanoid Form (DCD-490)
PITTSBURGH, Aug. 12, 2025 /PRNewswire/ -- "I'm an analyst in the AI field, and I wanted to create a robot with a humanoid form to serve as an experimental platform for robotic studies and interactions," said an inventor, from Upper Marlboro, Md., "so I invented the ANDROID HUMANOID. My design would combine AI, basic humanoid mobility, a distinct appearance, and voice interactive capabilities." The patent-pending invention provides a robotic humanoid droid device. In doing so, it could be used for the study of bipodal motion and interactions with humans. It also would be able to navigate halls, stairs, and other areas without bumping into furniture or fixtures. Additionally, it would provide a wide range of interactions with humans for studying the impacts of robotic technology on society. The invention features an innovative design that is easy to use so it is ideal for households. The original design was submitted to the Washington DC sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 24-DCD-490, InventHelp, 100 Beecham Drive, Suite 110, Pittsburgh, PA 15205-9801, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at View original content to download multimedia: SOURCE InventHelp
